Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 730-739)

DR GILL HART, MR RICHARD GUTOWSKI, MS HELEN YOUNG AND MR ANDREW DILLON

15 MARCH 2007

  Q730Chairman: Could I start by welcoming those who have come to give evidence to us and members of the public who have come here today for our 11th public hearing of the inquiry into Allergy. There is an information note in which all members of the Committee declare their interests so we will not be repeating those today because they are on the record already. I wonder if I might start, I am Lady Finlay, I chair the Sub-Committee inquiry and I wonder if I might start by asking you to introduce yourselves and then we will go into the questions. During the questions it will be really helpful if you can keep your answers as tight as possible because we have got a lot of questions that we want to ask you, it means that we can get through them, otherwise we will have to stop. The other thing is that the acoustics in this room are not very good, so please speak up and speak clearly, this is being webcast. Please start, Dr Hart.

  Dr Hart: I am Dr Gill Hart. I am the Technical Director at York Test Laboratories Ltd and I am a biochemist with expertise in the development of diagnostic tests.

  Mr Gutowski: I am Richard Gutowski from the Medicines and Healthcare Products Regulatory Agency which is an executive agency in the Department of Health and I have responsibility for compliance issues relating to medical devices.

  Ms Young: I am Helen Young and I am the Clinical Director and Chief Nurse for NHS Direct which, as the Committee will know, is the telephone, web and digital television service for the NHS.

  Mr Dillon: I am Andrew Dillon and I am Chief Executive of the National Institute for Health and Clinical Excellence.

  Q731  Chairman: Thank you very much indeed. I wonder if I could start by asking you what types of allergy self-testing kits are available to the public and where they can be obtained?

  Dr Hart: I can just speak about the services that York Test provide. York Test provide an allergy screening test, which is an IgE test for allergy, direct to the public. The public have a sample taken, a full blood draw by their GP or phlebotomist, the sample is posted to us and we run it on a test in our laboratory. In addition, we provide a service for IgG testing, a service direct to the public, again a sample kit is sent out to the general public, they provide the blood sample, post it back to the laboratory and we provide the results. We are very aware that this is a huge responsibility in that we do not provide the consumer with healthcare professional involvement and we have taken this very seriously, so much so that we have put our testing services through the same route as would be applicable to a self-test kit which was on the shop floor in Boots and we have put it through that regulatory procedure which I can tell you more about later.

  Q732  Chairman: Mr Gutowski, do you have anything to add to that?

  Mr Gutowski: Yes, I have. The majority of allergy test kits are called skin prick tests and the substance in the test kit is inserted into the body to produce a reaction and these kits are in fact regulated as medicinal products.

  Q733  Chairman: They are not self-tests, are they?

  Mr Gutowski: No, they are medicinal products and they are prescription only medicinal products, so they are not available to the public unless the GP initially writes a prescription, but, in the main, they are used in testing laboratories either in general practice or in hospitals. There are allergy test kits which are regulated as medical devices, and I will come onto the distinction later because I think there is a separate question on that, and these are in the main used by testing services as you have just heard and we are only aware, and this is from our intelligence, of one of these kits being available to the general public over the counter. Most of these IVD test kits are used by testing services where the patient will send the sample to the testing house and either he will receive the results back or his general practitioner will.

  Q734  Chairman: Dr Hart, when you do IgE testing, do you send that result back to the GP?

  Dr Hart: We give the customer the option of having the results sent back to the GP or not and in most cases they choose not to have their results sent back to their GP. In putting the services that we provide through the IVD Directive as a self-test testing service, we have given evidence to the notified body that represents the MHRA which shows that the lay user in this case can interpret the results that we provide, or has the MHRA's approval that the lay user can interpret the results that we provide and act upon them on their own without healthcare professional involvement.

  Q735  Chairman: I wonder if I could ask Ms Young and Mr Dillon whether NHS Direct recommend the use of any self-test kits and whether any have been subject to a NICE appraisal?

  Ms Young: From NHS Direct's perspective all that we would offer in this particular area is health information advice in relation to evidence that exists that a call or a visit to the website could access to make a judgment about what type of product might be suitable and what type of questions they may wish to ask their general practitioner. We do not make specific recommendations to a particular product, we would simply advise and give information on specific questions that were asked of us.

  Q736  Chairman: Are there any self-testing kits or concepts that you are advising to patients who clock on with allergy?

  Ms Young: To the best of my knowledge most of the information on our website and that we would advise on is based on the referral to either a specialist, or, indeed, through the general practitioner.

  Q737  Chairman: Mr Dillon?

  Mr Dillon: No, is the short answer to your question.

  Q738  Lord Colwyn: I am muddled about self-testing. Self-testing to me means something that the patient does themselves. Can you explain it?

  Dr Hart: Absolutely. Self-testing in my definition is when a consumer receives a result, whether it be at home in doing the self-test kit that they bought in Boots or whether it be the provision of a result given to that person from a testing laboratory. My interpretation of the regulations is that they should both be regulated as self-testing services because no healthcare professional is involved. I think there is great confusion about the distinction between the allergy kit or the pregnancy kit that you buy in Boots compared with the testing service result that the consumer can also access very readily over the Internet in Holland & Barrett and various other places where people can get allergy and food intolerance tests which do not appear to be fully regulated.

  Mr Gutowski: If I could add something to that, it may be of help. The concept of the self-test kit is enshrined within the medical device regulations and it is based on the concept that the test is carried out by a lay person in their home environment, so they would take the test, whether they have been given it by a general practitioner or purchased it over the counter, whether it be an allergy or a pregnancy test kit, they will do the test at home and the kit itself will give them a result at home with instructions that came with the kit as to how to make a determination on the basis of a colour change or whatever as to what the results of that test is.

  Q739  Baroness Perry of Southwark: Do those definitions include any distinction between whether you read the result of your test yourself at home as a lay person, or if you send the sample away and somebody expert gives you the result?

  Dr Hart: I understand that in 2004 the MHRA and notified bodies jointly decided that not only IVD products, that is the kits, but also IVD testing services are the direct end users or consumers without the involvement of healthcare professionals are designated self-tests and it is my understanding of the regulation that the CE marking for these services was given a two year extension from 2003 to 2005, so from 7 December 2005 all testing services that provide results back to lay users should be equally regulated as the kits that can be bought in Boots. I think that is what should happen, it is something that we comply with at York Test, but it is not common practice.


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2007